Find out how to deal online from £1.50 in a SIPP, ISA or Dealing Account.
Jump to:

Oxford BioMedica Fundamentals

Company Name Oxford Biomedica Last Updated 21 Aug 2019
Industry Health Care Sector Pharmaceuticals
Shares in Issue (m) 76.77 Market Cap (£m) 489.78
PE Ratio 55.14 Div per Share () 0.00
Div Yield 0.00 Div Cover 0.00
EPS 11.57 EPS Growth (%) 4,089.66
PEG 0.01 DPS Growth (%) n/a
Debt Ratio 58.59 Debt Equity Ratio 0.63
Net Gearing 40.41 Gross Gearing 69.09
Asset Equity Ratio 3.24 Cash Equity Ratio 92.81
Quick Ratio 2.29 Current Ratio 2.44
Price To Book Value 14.10 ROCE 5.97

Oxford BioMedica Dividends

Type Ex-Date Pay Date Currency Net Dividend Year Total

Oxford BioMedica Company Financials

Assets (£m) 2018 2017 2016
Tangible Assets 32 25 28
Intangible Assets 0 0 1
Investments 11 3 1
Total Fixed Assets 43 28 30
Stocks 4 3 2
Debtors 31 17 7
Cash & Equivalents 32 14 15
Other Assets 2 2 3
Total Assets 112 65 57
Liabilities (£m) 2018 2017 2016
Creditors within 1 year 29 22 9
Creditors after 1 year 49 37 35
Other Liabilities 0 0 0
Total Liabilities 78 59 44
Net assets 35 6 13
Equity (£m) 2018 2017 2016
Called up share capital 33 31 31
Share Premium 172 154 154
Profit / Loss 5 -12 -20
Other Equity 4 4 2
Preference & Minorities 0 0 0
Total Capital Employed 35 6 13
Ratios 2018 2017 2016
Debt Ratio 58.59 85.92 73.51
Debt-to-Equity 0.63 0.63 0.79
Net Gearing 40.41 68.69 50.92
Gross Gearing 69.09 90.60 77.85
Assets / Equity 3.24 10.64 4.51
Cash / Equity 92.81 233.14 121.56
EPS 11.57 -0.29 -0.60
Cash Flow (£m) 2018 2017 2016
Cash from operating activities 13 3 -5
Cashflow before financing 3 1 -12
Increase in Cash 18 -1 6
Income (£m) 2018 2017 2016
Turnover 67 38 28
Cost of sales 23 18 12
Gross Profit 44 19 16
Operating Profit 14 -6 -11
Pre-Tax profit 5 -12 -20
Profit / Loss for the year 33 31 31

Oxford BioMedica Company Background

Sector Pharmaceuticals
Activities Oxford BioMedica plc is a leading gene and cell therapy group focused on developing life changing treatments for serious diseases. Oxford BioMedica and its subsidiaries (the Group) have built a sector leading lentiviral vector delivery platform (LentiVector), which the Group leverages to develop in vivo and ex vivo products both in-house and with partners. The Group has created a valuable proprietary portfolio of gene and cell therapy product candidates in the areas of oncology, ophthalmology and CNS disorders. The Group has also entered into a number of partnerships, including with Novartis, Sanofi, GSK, Orchard Therapeutics and Immune Design, through which it has long-term economic interests in other potential gene and cell therapy products. Oxford BioMedica is based across several locations in Oxfordshire, UK and employs more than 430 people.
Latest Interim Date 13 Sep 2018
Latest Fiscal Year End Date 14 Mar 2019

Oxford BioMedica Directors

Appointed Director Position
29 Aug 2008 John Andrew Dawson Chief Executive Officer
29 Aug 2017 Stuart Paynter Chief Financial Officer
01 Feb 2016 Dr Lorenzo Tallarigo Non-Executive Chairman
24 Jun 2019 Robert Evgeniev Ghenchev Non-Executive Director
15 Mar 2018 Dr Heather Elizabeth Preston Non-Executive Director
01 Jun 2016 Stuart Jonathon Brodie Henderson Non-Executive Director
01 Jan 2010 Dr Andrew John William Heath Non-Executive Director
04 Oct 2012 Martin Henry Diggle Non-Executive Director

Oxford BioMedica Contact Details

Company Name Oxford Biomedica
Company Address Medawar Centre, Robert Robinson Avenue, The Oxford Science Park, Oxford, OX4 4GA
Company Telephone +44 (0)1865 783 000
Company Website http://www.oxb.com/

Oxford BioMedica Advisors

Auditor Name PricewaterhouseCoopers LLP
Auditor Address 9 Greyfriars Road, Reading RG1 1JG.
Auditor Website http://www.pwc.co.uk/
Auditor Telephone +44 (0)
Registrar Name Capita Registrars
Registrar Address The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU.
Registrar Website http://www.capitaregistrars.com/
Registrar Telephone 0870 162 3100
Broker Name Nomura Code Securities
Broker Address 1 Carey Lane, London, EC2V 8AE.
Broker Website http://www.nomuracode.com/
Broker Telephone +44 (0)20 7776 1200
Adviser Name Nomura Code Securities
Adviser Address 1 Carey Lane, London, EC2V 8AE.
Adviser Website http://www.nomuracode.com/
Adviser Telephone +44 (0)20 7776 1200
Solicitor Name Morrison & Foerster
Solicitor Address City Point, One Ropemaker Street, London EC2Y 9AW.
Solicitor Website http://www.mofo.com/
Solicitor Telephone +44 (0)20 920 4000
Stockbroker Name n/a
Stockbroker Address n/a
Stockbroker Website n/a
Stockbroker Telephone n/a